Cargando…

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy

This study aimed to examine the efficacy of epirubicin-loaded gelatin hydrogel (EPI-H) in the treatment of superficial urothelium carcinoma. Hydrogel was prepared by Schiff base-crosslinking of gelatin with glutaraldehyde. EPI-H exhibited high entrapment efficiency (59.87% ± 0.51%). EPI-H also incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ching-Wen, Wu, Yu-Tse, Lin, Kai-Jen, Yu, Tsan-Jung, Kuo, Yu-Liang, Chang, Li-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274032/ https://www.ncbi.nlm.nih.gov/pubmed/27258243 http://dx.doi.org/10.3390/molecules21060712

Ejemplares similares

Preparation and Characterization of Gelatin-Based Mucoadhesive Nanocomposites as Intravesical Gene Delivery Scaffolds
por: Liu, Ching-Wen, et al.
Publicado: (2014)

Gel-Based Nanocarrier for Intravesical Chemotherapy Delivery: In Vitro and In Vivo Study
por: Chen, Ting-Yu, et al.
Publicado: (2020)

Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy
por: Chen, Ting-Yu, et al.
Publicado: (2020)

Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity
por: Yang, Fang, et al.
Publicado: (2017)

Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer
por: Suo, Ning, et al.
Publicado: (2019)

Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
por: Lu, Yilei, et al.
Publicado: (2022)

Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
por: Liu, J., et al.
Publicado: (2023)

Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
por: Chu, Tian‐Huei, et al.
Publicado: (2018)

Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel
por: Yoon, Ho Yub, et al.
Publicado: (2019)

Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation
por: Qiu, Xuefeng, et al.
Publicado: (2017)

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
por: Yamasaki, Miho, et al.
Publicado: (2019)

Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer
por: Chen, Cheng‐Che, et al.
Publicado: (2023)

WWOX Modulates ROS-Dependent Senescence in Bladder Cancer
por: Liu, Ching-Wen, et al.
Publicado: (2022)

Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis
por: Daryanto, Besut, et al.
Publicado: (2022)

Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation
por: Lin, Tingsheng, et al.
Publicado: (2016)

Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using mitomycin C or epirubicin for patients with non-muscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure
por: Chiancone, Francesco, et al.
Publicado: (2020)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer
por: Lu, Jiawei, et al.
Publicado: (2019)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
por: Ali-El-Dein, Bedeir, et al.
Publicado: (2013)

AB143. Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin
por: Li, Pengchao, et al.
Publicado: (2016)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
por: Won, Hye Sung, et al.
Publicado: (2020)

Self-Nanoemulsifying Drug Delivery System for Resveratrol: Enhanced Oral Bioavailability and Reduced Physical Fatigue in Rats
por: Yen, Ching-Chi, et al.
Publicado: (2017)

Progesterone Increases Apoptosis and Inversely Decreases Autophagy in Human Hepatoma HA22T/VGH Cells Treated with Epirubicin
por: Chang, Wen-Tsan, et al.
Publicado: (2014)

Intravesical liposome drug delivery and IC/BPS
por: Janicki, Joseph J., et al.
Publicado: (2015)

Research on Novel Intravesical Drug Delivery Devices
por: Moon, Hong Sang
Publicado: (2016)

Implantable Devices for Sustained, Intravesical Drug Delivery
por: Lee, Seung Ho, et al.
Publicado: (2016)

The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy
por: Zhou, Wenbin, et al.
Publicado: (2012)

Epirubicin-induced Kounis syndrome
por: Liang, Hui-zhu, et al.
Publicado: (2021)

Spatial and temporal profile of cisplatin delivery by ultrasound-assisted intravesical chemotherapy in a bladder cancer model
por: Sasaki, Noboru, et al.
Publicado: (2017)

Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer
por: Kato, Tomonori, et al.
Publicado: (2015)

A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
por: Lee, Jinsun, et al.
Publicado: (2014)

Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
por: Zhou, Wen-Bin, et al.
Publicado: (2010)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
por: Nieciecka, Dorota, et al.
Publicado: (2021)

Self-Nanoemulsifying Drug Delivery Systems for Enhancing Solubility, Permeability, and Bioavailability of Sesamin
por: Wang, Chih-Yuan, et al.
Publicado: (2020)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

GRP78 Knockdown Enhances Apoptosis via the Down-Regulation of Oxidative Stress and Akt Pathway after Epirubicin Treatment in Colon Cancer DLD-1 Cells
por: Chang, Yu-Jia, et al.
Publicado: (2012)

Insights into the Safety and Versatility of 4D Printed Intravesical Drug Delivery Systems
por: Uboldi, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ophoanjarandhn6g50jcf3r0v